Search results for: "johnson johnson"

(218 records)

Nuevolution agrees multi-target collaboration with Janssen Biotech

Will link up to develop new medicines for cancer, infections and inflammatory diseases

Alfa Aesar joins Thermo Fisher Scientific

Johnson Matthey completes the £256m transaction to sell its research chemicals business to US life science supplier

Johnson Matthey acquires Pharmorphix

Cambridge firm provides solid form services that are critical to successful drug discovery and development

UbiVac partners Johnson & Johnson Innovation to develop a vaccine against oral cancer

Will develop new preclinical and clinical versions of its proprietary DRibble immunotherapy
Ingredients
Johnson Matthey rebrands its Fine Chemicals Division

Johnson Matthey rebrands its Fine Chemicals Division

The rebranding is a key part of a custom-focused initiative to unite Johnson Matthey's diverse fine chemicals capabilities

Ontario Government, University of Toronto and MaRS secure JLABS incubator

JLABS @ Toronto will be a 40,000ft2 facility for up to 50 start-ups focused on biotechnology, pharmaceutical, medical device, consumer and digital health programmes

Prevalence of diabetes fuels market growth in India

Rising funds for diabetes control is also boosting growth of the diabetes drugs market in India

J&J announces immuno-oncology collaboration with Alligator Bioscience

Alligator will complete the current Phase I study and Janssen will be responsible for all subsequent product development

Johnson Matthey agrees sale of research chemicals business Alfa Aesar

Subject to typical preclosing conditions, the transaction is expected to be completed by the end of 2015

J&J Innovation announces 17 collaborations to focus on advancing global healthcare

Research alliance with Washington University marks first collaboration for Janssen Disease Interception Accelerator in type 1 diabetes

Janssen Pharmaceuticals enters into worldwide Hepatitis C collaboration with Achillion

Deal could potentially be worth US$1.1bn to Achillion
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory
New NCEs focus on cancer and orphan diseases

New NCEs focus on cancer and orphan diseases

The number of NCEs approved in Europe increased again in 2014, with the spotlight on cancer drugs and treatments for unmet medical needs. Dr Sarah Houlton reviews the new...

Johnson Matthey receives two pharmaceutical and biotech CMO Leaderships Awards in 2015

The awards are presented to companies achieving top ranking against various criteria and for specific industry segments

Janssen acquires XO1 Limited

Investigational anti-thrombin antibody Ichorcumab strengthens cardiovascular disease portfolio

Galapagos ends inflammation partnership with Janssen

Long-running alliance started in 2007

Alzheimer’s Research UK and J&J to back new US$100m Dementia Discovery Fund

Leading charity, UK government and pharmaceutical companies join forces to invest in dementia research

Trending Articles

  1. Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings The alliance pairs Loftware's SAP-integrated product identification platform with RiseNow's procurement and supply chain advisory services, delivering end-to-end track-and-trace capabilities for regulated industries where audit readiness and patient safety are critical
  2. AlzeCure receives $12m upfront as NeuroRestore Alzheimer's platform licensing deal with QuantumCell closes The payment — comprising $7m in licence fees and $5m direct investment — kicks off a collaboration worth more than $2.2bn in potential milestones, with QuantumCell assuming global rights to ACD856 and the NeuroRestore platform
  3. As new CTO, Christian Reichardt is driving the technological advancement of Optima Pharma This investment is driven by growth areas such as biologics, GLP-1 products, and other sterile pharmaceuticals, as well as the increasing demand for isolator and high-potency technologies
  4. Bespak awarded gold EcoVadis sustainability rating for its Holmes Chapel (UK) site Bespak, the specialist inhalation CDMO, has achieved a Gold EcoVadis sustainability rating for its Holmes Chapel site. The result places Bespak among the top 5% of companies assessed worldwide
  5. Irish manufacturer brings EU GMP-certified dronabinol API to UK specials market Dunbar Pharmaceuticals partners with IPS Pharma to supply plant-derived dronabinol API for UK Specials-pathway cannabis medicines, following its earlier expansion into Germany

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Manufacturing Labtex and Diehm
Partners in precise and sustainable glass reactor systems since 2005

Partners in precise and sustainable glass reactor systems since 2005

Read more
Sustainability Matt explains how the NSF QP Alumni community provides lasting professional connections, peer support and continuing development, helping Qualified Persons share challenges and...
Why QP Alumni connections continue to matter long after QP Training

Why QP Alumni connections continue to matter long after QP Training

Read more
Manufacturing High Point completes three regulatory inspections, enabling commercial API manufacturing for the US, Japan and Australia
Cambrex High Point completes FDA, PMDA and TGA pre-approval inspections, advancing commercial manufacturing capabilities

Cambrex High Point completes FDA, PMDA and TGA pre-approval inspections, advancing commercial manufacturing capabilities

Read more
Manufacturing Expansion adds commercial-scale batch tableting capacity and strengthens integrated ASD manufacturing
Hovione completes €40 million expansion of Loures tablet manufacturing center

Hovione completes €40 million expansion of Loures tablet manufacturing center

Read more
Manufacturing Pharmaceutical packaging, filling and digital technologies will be on display at the Milan exhibition
Marchesini Group showcases pharma and aseptic solutions at CPHI 2026

Marchesini Group showcases pharma and aseptic solutions at CPHI 2026

Read more
Manufacturing Combining expertise across the UK and US, Codis supports customers from material characterisation and formulation development through scale-up, clinical studies and through to...
Codis brings together formulation development, spray drying and commercial supply

Codis brings together formulation development, spray drying and commercial supply

Read more
Packaging The global market for weight management drugs is seeing dynamic growth and increases the demand for powerful self-injection systems
Schreiner MediPharm develops multifunctional label for SHL Medical’s Quanta Pen

Schreiner MediPharm develops multifunctional label for SHL Medical’s Quanta Pen

Read more
Analysis New brand identity and website mark the expansion of Tagomics’ product portfolio into organ health monitoring
Tagomics introduces a first-in-class cfDNA-based blood test for multi-organ drug safety monitoring

Tagomics introduces a first-in-class cfDNA-based blood test for multi-organ drug safety monitoring

Read more